[HTML][HTML] Hepatocellular carcinoma: therapy and prevention
HE Blum - World journal of gastroenterology, 2005 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide.
The major etiologies and risk factors for the development of HCC are well defined and some …
The major etiologies and risk factors for the development of HCC are well defined and some …
[HTML][HTML] Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus
T Wen, C Jin, A Facciorusso, M Donadon… - … surgery and nutrition, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the sixth-most common cancer and the third leading
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
cause of cancer-related death in the world. However, 40–70% patients eventually suffer from …
Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)
J Zhou, HC Sun, Z Wang, WM Cong, JH Wang… - Liver cancer, 2018 - karger.com
Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …
Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study
Z Wang, Z Ren, Y Chen, J Hu, G Yang, L Yu… - Clinical Cancer …, 2018 - AACR
Purpose: The survival of patients with hepatocellular carcinoma (HCC) recurrence after
curative resection is usually poor. We sought to evaluate the safety and efficacy of adjuvant …
curative resection is usually poor. We sought to evaluate the safety and efficacy of adjuvant …
[PDF][PDF] Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
YF Sun, Y Xu, XR Yang, W Guo, X Zhang, SJ Qiu… - …, 2013 - Wiley Online Library
Epithelial cell adhesion molecule–positive (EpCAM+) hepatocellular carcinoma (HCC) cells
may constitute a tumor‐initiating subpopulation in tumorigenic cell lines and HCC …
may constitute a tumor‐initiating subpopulation in tumorigenic cell lines and HCC …
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
D Hui, L Qiang, W Jian, Z Ti, K Da-Lu - Digestive and liver disease, 2009 - Elsevier
BACKGROUND: With a resistance to conventional chemotherapy and radiotherapy,
hepatocellular carcinoma has a high recurrence rate after radical resection. Adjuvant …
hepatocellular carcinoma has a high recurrence rate after radical resection. Adjuvant …
[HTML][HTML] A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma
Background The aim of this study was to systematically evaluate and determine those
patients with hepatocellular carcinoma (HCC) that would benefit from the administration of …
patients with hepatocellular carcinoma (HCC) that would benefit from the administration of …
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery
XR Yang, Y Xu, B Yu, J Zhou, JC Li, SJ Qiu, YH Shi… - Clinical Cancer …, 2009 - AACR
Purpose: To investigate the role of CD24 in tumor invasion and prognostic significance in
hepatocellular carcinoma (HCC). Experimental Design: CD24 expression was measured in …
hepatocellular carcinoma (HCC). Experimental Design: CD24 expression was measured in …
A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular …
C Zhong, R Guo, J Li, M Shi, W Wei, M Chen… - Journal of cancer …, 2009 - Springer
Purpose Hepatectomy is considered as the potentially curative treatment for hepatocellular
carcinoma (HCC) and used in some selected Stage IIIA HCC, which include multiple tumors …
carcinoma (HCC) and used in some selected Stage IIIA HCC, which include multiple tumors …
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate …
X Yin, L Zhang, YH Wang, BH Zhang, YH Gan, NL Ge… - BMC cancer, 2014 - Springer
Background This study was designed to evaluate the effectiveness of radiofrequency
ablation in patients with intermediate (BCLC B) stage hepatocellular carcinoma who …
ablation in patients with intermediate (BCLC B) stage hepatocellular carcinoma who …